When looking at molecular subgroups of CRC, a down-regulated expression of CDX2 was closely linked to CIMP-high (P < 0.001), MSI (P < 0.001) and BRAF mutated tumors (P < 0.001) (Table 2). This evidence concerns the gene CDX2 and colorectal carcinoma.